Evidence map›Paper›PMID 25149566›Full record

ArticleCell calcium2014

Ligand-selective activation of heterologously-expressed mammalian olfactory receptor.

K Ukhanov, Y Bobkov, E A Corey, B W Ache

Open access · greenAbstract read
In one paragraph

Article in Cell calcium, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Antagonists Enhance Cell-Surface Expression of Mammalian Odorant Receptors.International journal of molecular sciences · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

K UkhanovWhitney Laboratory, Center for Smell and Taste, and McKnight Brain Institute, University of Florida, Gainesville, FL 32610, United States. Electronic address: ukhanov@mbi.ufl.edu.
Y BobkovWhitney Laboratory, Center for Smell and Taste, and McKnight Brain Institute, University of Florida, Gainesville, FL 32610, United States.
E A CoreyWhitney Laboratory, Center for Smell and Taste, and McKnight Brain Institute, University of Florida, Gainesville, FL 32610, United States.
B W AcheWhitney Laboratory, Center for Smell and Taste, and McKnight Brain Institute, University of Florida, Gainesville, FL 32610, United States; Department of Biology, University of Florida, Gainesville, FL 32610, United States; Department of Neuroscience, University of Florida, Gainesville, FL 32610, United States.
University of Florida · USTaste and Smell Clinic · USWhitney Museum of American Art · US

Funding

MULTIPLE PATHWAYS IN OLFACTORY TRANSDUCTIONR01DC001655 · NIDCD · UNIVERSITY OF FLORIDA · PI ACHE, BARRY W. · 1992 to 2010
$3.0M
Phosphoinositide Signaling in Mammalian OlfactionR01DC005995 · NIDCD · UNIVERSITY OF FLORIDA · PI ACHE, BARRY W. · 2003 to 2015
$3.0M
NIDCD NIH HHS DC001655NIDCD NIH HHS DC005995NIDCD NIH HHS R01 DC001655NIDCD NIH HHS R01 DC005995
6 · The paper itself

Abstract

Mammalian olfactory receptors (ORs) appear to have the capacity to couple to multiple G protein-coupled signaling pathways in a ligand-dependent selective manner. To better understand the mechanisms and molecular range of such ligand selectivity, we expressed the mouse eugenol OR (mOR-EG) in HEK293T cells together with Gα15 to monitor activation of the phospholipase-C (PLC) signaling pathway and/or Gαolf to monitor activation of the adenylate cyclase (AC) signaling pathway, resulting in intracellular Ca(2+) release and/or Ca(2+) influx through a cyclic nucleotide-gated channel, respectively. PLC-dependent responses differed dynamically from AC-dependent responses, allowing them to be distinguished when Gα15 and Gαolf were co-expressed. The dynamic difference in readout was independent of the receptor, the heterologous expression system, and the ligand concentration. Of 17 reported mOR-EG ligands tested, including eugenol, its analogs, and structurally dissimilar compounds (mousse cristal, nootkatone, orivone), some equally activated both signaling pathways, some differentially activated both signaling pathways, and some had no noticeable effect even at 1-5mM. Our findings argue that mOR-EG, when heterologously expressed, can couple to two different signaling pathways in a ligand selective manner. The challenge now is to determine the potential of mOR-EG, and perhaps other ORs, to activate multiple signaling pathways in a ligand selective manner in native ORNs.

Indexed as

HeterozygoteAdenylyl CyclasesAnimalsCalciumCyclic AMPGene ExpressionHumansLigandsMammalsMiceMicrofilament ProteinsOlfactory Receptor NeuronsReceptors, OdorantSignal TransductionType C PhospholipasesAdenylyl CyclasesCalciumCyclic AMPLigandsMicrofilament ProteinsOlfr73 protein, mouseReceptors, OdorantType C PhospholipasesBiased signalingFunctional assayHEK293TmOR-EGOlfactory receptorolfr73

Identifiers

PMID25149566
PMCPMC4188773
OpenAlexW2059259591

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.